RE: Bravo Vlad27 Nov 2025 14:03
I know it appears difficult for you.
Notposting
Posted in: HEMO
Posts: 533
RE: The “LTHs” trading19 Nov 2025 23:27
It’s straight from the official documentation unlike the stuff you lot keep making up whenever it suits you. 😘 Keep trying to hide it. JustHereForFleecing, no one cares whether they sell or not, or about you using alias accounts to pretend you’re someone else. Your dishonesty is showing yet again.
To address this anticipated funding shortfall, the Group will require additional working capital of approximately £5.6 MILLION BY THE END OF JANUARY 2026 in order to continue its product development activities, with a primary focus on HG-CT-1, to the end of 2026 and an additional £10 million during the period from 2027 to 2028
The Group will have insufficient working capital after Admission, and further funds will be required to be invested in the first quarter of 2026 for the Group to continue its activities and thereafter to complete Phase I trials of HG-CT-1 in both adult and pediatric patients.
The Company is of the opinion that the working capital available to the Group will be insufficient for its present requirements, that is, for at least the next 12 months from the date of this document. Following Admission, the
Directors expect that the Group will have an aggregate funding shortfall of approximately £15.6 million to
That was the original post. I only expanded on it later because I was dealing with people who hadn’t even read the prospectus yet felt confident making uninformed comments. The additional emphasis was simply to address their points. So if we’re talking about manipulation, it’s worth asking who actually removed the context.
I posted the full abstracts verbatim on the day they were released, which anyone can see in my history. So, as I said, it’s not quite the “catch” some are claiming. Oopsie. x
But that reminds me actually.